Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna, +36

Journal of the National Comprehensive Cancer Network

Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementGastroenterology +11

Esophageal and Esophagogastric Junction Cancers, Version 1.2015

Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna, +34

Journal of the National Comprehensive Cancer Network

Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyMedicine +13

Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.

Shadan Ali, Khaldoun Almhanna, Wei Chen, +2

PubMed

Screening ToolsImmunologyPathologyTumor BiologyPancreatic Cancer +14

A phase II study of RO4929097 in metastatic colorectal cancer

Jonathan Strosberg, Timothy J. Yeatman, Jill Weber, +8

European Journal of Cancer

Gastrointestinal OncologyMedicineColorectal CancerPathologyMetastatic Colorectal Cancer +3

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Ronan J. Kelly, Jeeyun Lee, Yung‐Jue Bang, +21

Clinical Cancer Research

Defining the Learning Curve for Robotic-assisted Esophagogastrectomy

Jonathan M. Hernandez, Francesca Dimou, Jill Weber, +5

Journal of Gastrointestinal Surgery

Robotic SurgeryGastroenterologySurgical TrainingLearning CurveSurgery +3

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Bassel F. El‐Rayes, Mark M. Zalupski, T. Bekai-Saab, +10

Annals of Oncology

Esophageal CancerGastrointestinal OncologyMedicineGastroesophageal Junction CancersPharmacology +7

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

Irene Braña, Raanan Berger, Talia Golan, +16

British Journal of Cancer

Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal.

Chuong, William J. Fulp, Khaldoun Almhanna, +2

PubMed

Targeting AKT protein kinase in gastric cancer.

Khaldoun Almhanna, Jonathan Strosberg, Mokenge P. Malafa

PubMed

Chemotherapy ResistanceGastrointestinal OncologyCell SignalingMedicineReceptor Tyrosine Kinase +13